z-logo
open-access-imgOpen Access
Tadalafil once daily and intralesional verapamil injection: A new therapeutic direction in Peyronie′s disease
Author(s) -
Lucio Dell’Atti
Publication year - 2015
Publication title -
urology annals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.355
H-Index - 20
eISSN - 0974-7834
pISSN - 0974-7796
DOI - 10.4103/0974-7796.152048
Subject(s) - tadalafil , medicine , peyronie's disease , erectile dysfunction , erectile function , verapamil , urology , combination therapy , surgery , calcium
The aim of this study was to evaluate the combination of intralesional verapamil injection (IVI) therapy with and tadalafil in men affected by Peyronie's disease (PD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here